WENA - Anew Medical Forvard P/E multiplikatori

Anew Medical (WENA) kompaniyasining rasmiy ramzlari

Anew Medical, Inc. (WENA) neyrodegeneratsiyaga qarshi kurashish uchun Alpha-klotho protein gen terapiyasiga e'tibor qaratadi. Kompaniya moslashuvchanlikni saqlab qolish uchun ishlab chiqarish jarayonlari va sinovlarni tashqi pudratchilarga topshiradi. Biroq, ALS va Altsgeymer kasalliklarining erta bosqichdagi davolash usullariga e'tibor qaratilishi yuqori binariy xatarlarni yuzaga keltiradi. Biznesning forward P/E ko'rsatkichi aksiya narxining kutilayotgan foydaga nisbatini ifodalaydi, bunda ushbu metrika 0.00 ga tengdir.

Anew Medical Inc. - WENA Prognoz qilingan narxning foydaga nisbati (davr: 25.06.2024 - 17.09.2024)

Anew Medical (WENA) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Kompaniyaning barcha koʻrsatkichlari tahlili:Anew Medical, Inc.
anewmeds.com brend mahsuloti

Anew Medical, Inc. (WENA) kompaniyasining operatsion muvaffaqiyatini ob'ektiv baholash uchun investorlar bozor kutuvlarini uning oqsil yetkazib berish patentlarining tijoratlashtirish salohiyati bilan solishtirishlari kerak. Kompaniyaning 0.00 miqdorida qayd etilgan forward P/E koeffitsiyentini tahlil qilish orqali aksiyalar narxiga kiritilgan kelajakdagi foyda yillarini aniqlash mumkin, bu esa qarzlar yo'qligida uning biotexnologik ishlanmalarining uzoq muddatli qiymatini baholash imkonini beradi.

Anew Medical, Inc. kimlar bilan raqobatlashadi

Forvard P/E multiplikatori BIIB|NBIX - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RGC (Regencell Bioscience Ltd)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati axsome.com (AXSM)|ACADIA Pharmaceuticals Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Xenon Pharmaceuticals Inc.|Viking Therapeutics (VKTX) - Kelajakdagi narxning foydaga nisbati|Supernus Corp - Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati CPRX|Denali Therapeutics Inc. (DNLI) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati HRMY (Harmony Corp)|BHVN - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narxning foydaga nisbati Amylyx Pharmaceuticals, Inc. AMLX|Kelajakdagi narx-foyda multiplikatori TRVI|PRAX - Kelajakdagi narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Anavex Life Sciences AVXL|CBLL: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Prothena Corporation PLC|ALEC (alector.com) - Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Annexon, Inc. (ANNX)|Kelajakdagi narxning foydaga nisbati Omeros Corporation (OMER)|Neurogene Inc. - Narxning kelajakdagi foydaga nisbati|acimmune.com - Prognoz qilingan narxning foydaga nisbati|Forvard P/E multiplikatori Voyager Therapeutics Inc VYGR|NMRA - Kelajakdagi narxning foydaga nisbati|Forvard narx-foyda multiplikatori Scilex Holding Company (SCLX)|Tevogen Bio Holdings (TVGN) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati ACOG|Kelajakdagi narxning foydaga nisbati Cognition Therapeutics, Inc.|Inhibikase Therapeutics, Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati SAVA (Cassava)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Assertio Therapeutics|Coya Therapeutics, Inc. - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati VTGN (VistaGen Therapeutics Inc)|Ovid Therapeutics Inc - Forvard P/E multiplikatori|Acumen Pharmaceuticals, Inc. (ABOS) - Prognoz qilingan narxning foydaga nisbati|CRVO (CervoMed, Inc.) - Prognoz qilingan narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Alterity Therapeutics Ltd|Kelajakdagi narxning foydaga nisbati Clene Inc.|PepGen Inc. - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati JUNS (Jupiter Neurosciences Inc)|Kelajakdagi narxning foydaga nisbati RLMD (Relmada Therapeutics Inc)|Annovis Bio Inc - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Grace Tx (GRCE)|fireflyneuro.com - Forvard P/E multiplikatori|Klotho Neurosciences (KLTO) - Prognoz qilingan narxning foydaga nisbati|NeuroSense Therapeutics, Ltd. (NRSN) - Kelajakdagi narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati RVPH (Reviva Pharmaceuticals Holdings, Inc.)|MTVA (MetaVia) - Forvard P/E multiplikatori|NRXS: Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori HSDT|Forvard P/E multiplikatori Passage Bio Inc. (PASG)|Kelajakdagi narxning foydaga nisbati bionomics.com.au NEUP|Forvard P/E multiplikatori Minerva Neurosciences Inc NERV|ATHA: Prognoz qilingan narxning foydaga nisbati|ADXN (Addex Therapeutics, Ltd.) - Narxning kelajakdagi foydaga nisbati|Alzamend Neuro Inc. (ALZN) - Kelajakdagi narxning foydaga nisbati|Cyclerion - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati protagenic.com|Pasithea Therapeutics - Narxning kutilayotgan foydaga nisbati|Prognoz qilingan narxning foydaga nisbati CRGT (Cortigent, Inc.)|Avenue Therapeutics - Narxning kelajakdagi foydaga nisbati|Kelajakdagi narxning foydaga nisbati Brainstorm Cell BCLI|Forvard P/E multiplikatori caratherapeutics.com CARA|Chromocell Therapeutics Corp. - Forvard P/E multiplikatori|eliemtx.com - Kapitalizatsiyaning kelajakdagi foydaga nisbati|Intra-Cellular Therapies (ITCI) - Kelajakdagi narxning foydaga nisbati|LBPH (Longboard) - Kelajakdagi narxning foydaga nisbati|MRNS (marinuspharma.com) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati NKGen Biotech NKGN|Kelajakdagi narxning foydaga nisbati NeuroBo Pharma (NRBO)|Kapitalizatsiyaning kelajakdagi foydaga nisbati SAGE|Synaptogenix, Inc. - Prognoz qilingan narxning foydaga nisbati|TRVN: Narxning kelajakdagi foydaga nisbati|VIGL - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CERE (Cerevel Therapeutics)